Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
about
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon α-2a and Ribavirin for Chronic Hepatitis CAnti-Golgi autoantibodies: prevalence and disease associations in a rheumatic disease population.Dissecting the Role of Disturbed ER-Golgi Trafficking in Antivirals and Alcohol Abuse-Induced Pathogenesis of Liver Disorders.
P2860
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@en
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@nl
type
label
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@en
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@nl
prefLabel
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@en
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@nl
P2093
P2860
P1433
P1476
Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
@en
P2093
Christian Trepo
Liana Codes
Luiz A R de Freitas
Maria Isabel Schinoni
Marla Cruz
Raymundo Paraná
P2860
P304
P356
10.1111/J.1478-3231.2006.01345.X
P577
2006-11-01T00:00:00Z